End Taxpayer Funding of Gender Experimentation Act of 2025

# End Taxpayer Funding of Gender Experimentation Act of 2025 (HR 2202) **What the Bill Would Do** This bill would prohibit federal funding from being used for gender-affirming medical treatments and related services. If passed, it would restrict Medicare, Medicaid, and other federal health programs from covering procedures and medications associated with gender transition, including surgical procedures and hormone therapy. **Who It Affects** The bill would primarily affect transgender and non-binary individuals who rely on federal health insurance programs (Medicare and Medicaid) to cover gender-affirming care. It could also impact medical facilities and healthcare providers who currently receive federal reimbursement for these services, as well as federal employees and military personnel who access care through federal health benefits. **Current Status** As of now, HR 2202 is in committee, meaning it has not yet been debated or voted on by the full House.

The bill was introduced by Representative Doug LaMalfa (R-CA) in the 119th Congress. No additional legislative action has been taken, so it remains in the early stages of the legislative process.